Australian Prescriber Podcast cover art

Australian Prescriber Podcast

Australian Prescriber Podcast

By: Australian Prescriber
Listen for free

The Australian Prescriber Podcast provides a regular dive into some of the many great articles that Australian Prescriber publishes every two months. In each episode, our host will chat with one of the authors from a recent issue of Australian Prescriber.https://www.tg.org.au/copyright-permission/ Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • E215 - Vitamin B12 deficiency: testing and treatment

    E215 - Vitamin B12 deficiency: testing and treatment
    May 25 2026

    David Liew speaks to haematologist Cecily Forsyth about her paper on vitamin B12 testing and treating deficiency. They discuss the causes, notable risk factors, and clinical signs and symptoms of B12 deficiency. Cecily also outlines testing as well as management strategies for patients diagnosed with B12 deficiency, and the importance of long-term adherence with B12 replacement. Read the full article in Australian Prescriber.
    Show More Show Less
    21 mins
  • E214 - Therapeutic Guidelines Kidney and Urinary

    E214 - Therapeutic Guidelines Kidney and Urinary
    May 11 2026

    Therapeutic Guidelines expert group member Lee Fong returns to the podcast to talk to Justin Coleman about the brand-new Kidney and Urinary guidelines. Focusing on GP management, the conversation covers some of the new content, including screening and medication regimens for chronic kidney disease, lower urinary tract symptoms, wetting in children and much more.
    Show More Show Less
    19 mins
  • E213 - Metabolic dysfunction–associated fatty liver disease an update

    E213 - Metabolic dysfunction–associated fatty liver disease an update
    Apr 27 2026

    Laura Beaton talks to hepatology research fellow Richard O'Halloran about his paper on metabolic dysfunction–associated fatty liver disease (MAFLD). Richard outlines risk factors and comorbidities to consider, and diagnostic tests for MAFLD. The conversation also covers management of MAFLD through risk stratification, addressing health risk behaviours, and surveillance. Read the full article in Australian Prescriber.
    Show More Show Less
    16 mins
adbl_web_anon_alc_button_suppression_c
No reviews yet